Lipid profile alterations in subclinical hypothyroidism

Endocrinologist

Volumn 14, Issue 3, 2004, Pages 121-125

  Cabral, Monica Dias ^a,b   Costa, Antonio Jose Leal ^a   Santos, Mario ^a   Vaisman, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Atherosclerosis; Lipids; Subclinical hypothyroidism

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SYMPTOM; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 2542478094     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000127928.08840.b7     Document Type: Article

References (30)

1. Ayala A, Wartofsky L. Minimally symptomatic (subclinical) hypothyroidism. Endocrinologist. 1997;7:44-50.
2. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 1995;173:808-812.
3. Staub JJ, Althaus UB, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92:631-639.
4. Cooper D. Subclinical hypothyroidism. JAMA. 1987;258:246-247.
5. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty year follow-up of the Whickham survey. Clin Endocrinol. 1995;43:55-68.
6. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534.
7. Helfand M, Redfern CC. Screening for thyroid disease: an update. Clinical guideline, part 2. Ann Intern Med. 1998;129:144-158.
8. Lindeman RD, Schade DS, La Rue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatric Soc. 1999;47:703-709.
9. Bastenie PA, Vanhaelst L, Golstein J, et al. Asymptomatic autoimmune thyroiditis and coronary heart disease: cross sectional and prospective studies. Lancet. 1977;ii:155-158.
10. Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women. Ann Intern Med. 2000;132:270-278.
11. Vanderpump MP, Tunbridge WMG, French JM, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6:155-160.
12. Ball MJ, Griffiths D, Thorogood M. Asymptomatic hypothyroidism and hypercholesterolaemia. J R Soc Med. 1991;84:527-529.
13. Dickman T, Lansberg PJ, Kastelein JP, et al. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med. 1995;155:1490-1495.
14. Nilsson G, Nordlander S, Levin K. Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med Scand. 1976;200:63-67.
15. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481-493.
16. Kutty K, Bryant DG, Farid N. Serum lipids in hypothyroidism-a re-evaluation. J Clin Endocrinol Metab. 1978;46:55-56.
17. Bauer DC, Ettinger B, Browner WS. Thyroid function and serum lipids in older women: a population-based study. Am J Med. 1998;104:546-551.
18. Ayala AR, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin North Am. 2000;29:399-415.
19. Cooper D. Subclinical hypothyroidism. N Engl J Med. 2001;345:260-265.
20. Vanderpump MPJ, Ahlquist JAO, Franklyn JA, et al. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ. 1996;313:539-544.
21. Danese M, Ladenson P, Meinert C, et al. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85:2993-3001.
22. Evered DC, Ormston BJ, Smith PA, et al. Grades of hypothyroidism. BMJ. 1973;1:657-661.
23. Elder J, McLelland A, O'Reilly DS, et al. The relationship between serum cholesterol and serum thyrotropin, thyroxine and tri-iodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem. 1990;27:110-113.
24. Kung AWC, Pang RWC, Janus ED. Elevated serum lipoprotein (a) in subclinical hypothyroidism. Clin Endocrinol. 1995;43:445-449.
25. Engler H, Riesen W. Effect of thyroid function on concentrations of lipoprotein (a). Clin Chem. 1993;39:2466-2469.
26. Kurbaan AS, Isley GDJ. Normalization of lipoprotein (a) following successful treatment of hypothyroidism. QJM. 1995;88:221-223.
27. Yamamoto K, Iwata O, et al. Serum lipoprotein (a) levels before and after subtotal thyroidectomy in subjects with hyperthyroidism. Metabolism. 1995;44:4-7.
28. Yildirimkaya M, Ozata M, Yilmaz K, et al. Lipoprotein (a) concentration in subclinical hypothyroidism before and after levothyroxine therapy. Endocr J. 1996;43:731-736.
29. Spandrio S, Sleiman I, Scalvini T, et al. Lipoprotein (a) in thyroid dysfunction before and after treatment. Horm Metab Res. 1993;25:586-589.
30. Arem R, Escalante N, Morrisett JD, et al. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein (a). Metabolism. 1995;44:1559-1563.